As of Dec. 28, Michigan’s flu shot uptake -- less than 2.5 million doses -- sat far below its goal of 4 million doses ...
State and federal data show high levels of respiratory illnesses. Here's what to know about the illnesses circulating this ...
Patients are piling up in Minnesota emergency rooms once again, but it’s not just from COVID-19. State health officials say ...
The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...
Respiratory virus season is worsening. Nearly five years since the COVID-19 pandemic took hold, disease experts are urging ...
For immunocompromised individuals, antibody response to RSV vaccines is heterogeneous and about 40% do not seroconvert.
The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, stomach flu and COVID-19.
Respiratory syncytial virus (RSV) was first identified as a cause of human infection more than six decades ago, after the virus was isolated from respiratory swabs from two children with outpatient ...
Respiratory syncytial virus, or RSV, is a common virus that infects the nose, throat and lungs, according to the U.S. Centers for Disease Control and Prevention. Is it RSV, COVID or the flu?